In a momentous collaboration, Stony Brook Medicine and Mount Sinai Health System have entered into an affiliation agreement to include research collaboration, academic programs and clinical care initiatives.
Combining expertise from two premier medical schools, the partnership offers boundless possibilities to promote discovery, enrich academic medicine and enhance clinical care through large-scale research and clinical collaborations that will transform healthcare from Manhattan to Montauk and beyond.
Stony Brook and Mount Sinai will collaborate to develop a wide range of research programs in fields such as biomedical engineering and computer science; drug discovery and medicinal chemistry sciences; neuroscience; neurology and psychiatry; basic biology and novel therapeutics; and public health and health systems.
Boundless Possibilities
This alliance will capitalize on Stony Brook University’s expertise in mathematics, high-performance computing, imaging, and the physical and chemical sciences, and Mount Sinai’s strengths in biomedical and clinical research, and health policy and outcomes.
Mount Sinai and Stony Brook will invest a combined $500,000 to launch competitive and unique pilot research programs, with the intent to receive collaborative external funding. Projects will be determined and overseen by a committee comprised of three representatives from each institution.
These heightened academic and research synergies will help promote discovery, expand clinical trials and advance the development of breakthroughs to understand and treat disease. The opportunities for amazing science to spring from these collaborative efforts are truly boundless.
Leaders from Stony Brook Medicine and Mount Sinai Health System sign an affiliation agreement between the two institutions during the Stony Brook ceremony. From left: Kenneth Kaushansky, MD, Senior VP, Health Sciences and Dean, Stony Brook University School of Medicine; Samuel L. Stanley Jr., MD, President, Stony Brook University; and Dennis S. Charney, MD, the Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai, and President, Academic Affairs, Mount Sinai Health System.
Stony Brook University President Samuel L. Stanley Jr., MD, Center, shakes hands with Kenneth Kaushansky, MD, Senior VP, Health Sciences and Dean, Stony Brook University School of Medicine (left), and Dennis S. Charney, MD, the Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai, and President, Academic Affairs, Mount Sinai Health System (right) during the Stony Brook affiliation signing agreement event between the two institutions.
Stony Brook and Mount Sinai leaders, along with public officials, assemble at the affiliation agreement signing event at Stony Brook. From left: Assemblyman Steven Englebright; Scott Friedman, MD, Dean of Therapeutic Discovery at Icahn School of Medicine at Mount Sinai; Dennis S. Charney, MD, the Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai; Stony Brook University President Samuel L. Stanley Jr., MD; Kenneth Kaushansky, MD, Senior VP, Health Sciences and Dean, Stony Brook University School of Medicine; Senator Kenneth LaValle; Senator Kemp Hannon; and Lina Obeid, MD, Dean for Research and Vice Dean for Scientific Affairs, Stony Brook University School of Medicine.
Stony Brook and Mount Sinai leaders assemble at the affiliation agreement signing event at Stony Brook. From left: Reginald W. Miller, DVM, DACLAM, Dean for Research Operations and Infrastructure, Icahn School of Medicine at Mount Sinai; Scott Friedman, MD, Dean of Therapeutic Discovery at Icahn School of Medicine at Mount Sinai; Marta Filizola, PhD, Dean, Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai; Dennis S. Charney, MD, the Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai; Stony Brook University President Samuel L. Stanley Jr., MD; Kenneth Kaushansky, MD, Senior VP, Health Sciences and Dean, Stony Brook University School of Medicine; and Lina Obeid, MD, Dean for Research and Vice Dean for Scientific Affairs, Stony Brook University School of Medicine.